16
Jun
2026

SHANDONG LUKANG PHARMACEUTICAL CO., LTD.

Exhibitor at CPHI & PMEC China 2026 stand W1E30, Pharma Ingredients
About Us

Established in 1966, Shandong Lukang Pharmaceutical Co., Ltd. (Abbr. Lukang Pharma) is now one of the leading vertically integrated pharmaceutical enterprises in China, engaged in developing, manufacturing, and commercializing API and Finished Dosage Form of Human Drugs, Animal Health, Bio-pesticides, and also general undertaking of CMO business. At present, Lukang Pharma has about $ 1.3 billion in total assets. It covers an area of 3.0 square kilometers, has more than 6000 employees and owns 5 wholly-owned subsidiaries, 6 holding subsidiaries and 2 joint stock companies, 5 of which are High Technology Enterprise of National Level. There are 3 R&D centres and 5 pilot platforms throughout the country. Brief Introduction of Lukang Pharma Lukang Pharma is an EU GMP, FDA, cGMP and Chinese GMP certified enterprise. Our products got CEP certificates from 2003. And the first in the pharmaceutical industry through the ISO 9001, ISO 14001, ISO 45001 system certification since 1992. Lukang Pharma always commits itself to offering high-quality & trustworthy products to keep life away from disease. Lukang Pharma is present across varied therapies such as antibiotics, cardiovascular, endocrine, antipyretic and analgestic, neurodegenerative, respiratory, traditional Chinese medicine and animal health products etc. Many products occupy industry-leading position. 18 types of products rank No.1 and 67 products within top 10 in China. The products are exported to EU, USA, Britain, Russia, India, Brazil, Japan and totally more than 90 countries and areas. Lukang Products are more and more popular at home and abroad. To cultivate and promote the core competitiveness by consistently delivering high quality, safe and effective products and services that meet customer expectations across the globe through current good manufacturing practices, state of the art technology, competent workforce and efficient management, we strive to achieve the mission every day.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand W1E30, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • 7-ACA cephalosporins

    Product 7-ACA cephalosporins

    Assay: 98%-102%. Packing: 25kg/drum.
  • Acetyl Spiramycin

    Product Acetyl Spiramycin

    Acetyl Spiramycin 20kg/drum
  • Ampicillin Sodium Sterile

    Product Ampicillin Sodium Sterile

    Ampicillin Sodium sterile--Lyophilized
    Packing: 7kg/tin, 2 tins/carton
  • CEFAZOLIN SODIUM

    Product CEFAZOLIN SODIUM

    Cefazolin Sodium is the sodium salt of cefazolin, a beta-lactam antibiotic and first-generation cephalosporin with bactericidal activity. Cefazolin binds to and inactivates penicillin -binding...
  • CEFTIOFUR SODIUM, CEFTIOFUR HYDROCHLORIDE

    Product CEFTIOFUR SODIUM, CEFTIOFUR HYDROCHLORIDE

    Ceftiofur sodium is a third generation broad spectrum cephalosporin, formulated as an intramuscular injection, which is used to treat respiratory diseases in swine, ruminants and horses.&...